A Phase III Study to Assess the Efficacy and Safety of GV1001-Gem/Cap vs Gem/Cap in Pancreatic Cancer Patients

Press/Media: Press / Media

Period2018 Oct 2

Media coverage

1

Media coverage

  • TitleA Phase III Study to Assess the Efficacy and Safety of GV1001-Gem/Cap vs Gem/Cap in Pancreatic Cancer Patients
    Media name/outletClinical Trials.gov
    CountryUnited States
    Date18/10/2
    PersonsTae Kyu Kim